Polarean Imaging Ltd (POLX) ORD GBP0.00037
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Polarean gets first de novo order for Xenoview polariser
7 December 2023 16:01
(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.
-
Polarean Imaging enters strategic partnership with VIDA Diagnostics
8 September 2023 14:12
(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.
-
Polarean's Xenoview gets US reimbursement code
29 August 2023 14:22
(Sharecast News) - Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services...
-
Polarean Imaging gets first order for 'Xenoview'
26 April 2023 12:46
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Wednesday that it has received its first order for a gas-blend cylinder for the production of 'Xenoview', or...
-
Polarean Imaging appoints director as strategic consultant
17 April 2023 12:11
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the appointment of non-executive director Daniel Brague as a consultant, with immediate effect.
-
Polarean receives FDA approval for drug device combination product
28 December 2022 08:10
(Sharecast News) - Medical imaging technology group Polarean said on Wednesday that its drug device combination product has been granted approval by the US Food and Drug Administration.
-
Polarean inks long Covid research deal with Oxford NHS trust
11 May 2022 12:58
(Sharecast News) - Medical imaging technology company Polarean announced a research collaboration with Oxford University Hospitals NHS Foundation Trust (OUH) on Wednesday, to study the long-term effects of...
-
Polarean Imaging receives research order from long-standing partner
25 April 2022 09:11
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a xenon polariser '9820', it announced on Monday.
-
FDA accepts Polarean's medical imaging drug-device resubmission
20 April 2022 12:41
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon'...
-
Polarean installs xenon polariser system at Vancouver hospital
11 October 2021 15:00
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the installation of its 9820 xenon polariser system at BC Children's Hospital in Vancouver on Monday.
-
Polarean Imaging upbeat on progress as losses widen
4 June 2021 12:41
(Sharecast News) -
-
Polarean Imaging gets another research unit order
10 May 2021 13:49
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a '9820 Xenon Polariser' system from the University of British Columbia...
Company announcements Announcements
-
Exercise of Warrants, Issue of Equity and TVR
14 March 2024 07:00
Polarean Imaging
-
Holding(s) in Company
12 March 2024 15:59
Polarean Imaging
-
2024 Polarean Strategy Update
29 February 2024 07:00
Polarean Imaging
-
Block Listing Six Monthly Return
26 January 2024 07:00
Polarean Imaging
-
Comment re: share purchase
15 January 2024 07:00
Polarean Imaging
-
Holding(s) in Company
12 January 2024 17:00
Polarean Imaging
-
Holding(s) in Company
12 January 2024 17:00
Polarean Imaging
-
Company Update
7 December 2023 07:00
Polarean Imaging
-
Holding(s) in Company
27 November 2023 07:00
Polarean Imaging
-
Directorate Change
27 September 2023 13:59
Polarean Imaging
-
Partnership with VIDA
8 September 2023 07:00
Polarean Imaging
-
Half-year Report
7 September 2023 16:54
Polarean Imaging
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.